Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/11/2020
NHC Releases 2019 Annual Health Sector Development Report (Full Summar...
6/11/2020
Alphamab and Institut Pasteur Shanghai Announce Partnership to Co-deve...
6/11/2020
Lyvgen Announces Partnership With MSD for LVGN6051/Keytruda Combo
6/11/2020
Jiangsu Hengrui Terminates China License of Telomelysin with Oncolys
6/10/2020
NHC Seeks Comments on Draft Notice for Contemporary Clinical Regulatio...
6/10/2020
MSD Gains IND Approval for Prevymis (Letermovir) in China
6/10/2020
CANbridge Forms Rare Disease Gene Therapy Research Pact with UMass Med...
6/10/2020
Gan & Lee to Launch IPO on Shanghai STAR Market
6/9/2020
WuXi Biologics Leases Third U.S. Manufacturing Facility in Global Expa...
6/9/2020
JW Therapeutics Completes $100M Series B Financing Round
6/9/2020
Helsinn Announces Launch of Oral Formulation of Akynzeo in China
6/9/2020
PHIIC: Urban Chinese Hospital Drug Market Declined 25% in Q1
6/8/2020
Alphamab and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cance...
6/8/2020
Innovent and Roche Partner to Discover and Develop Multiple Products
6/8/2020
CASI Pharma Submits IND To Conduct Phase 1 Study For Anti-38 mAb in UK
6/8/2020
Chinese CMDO MabPlex Nets CNY 500M in Series B Round
6/8/2020
CDE Issues New Regulation for and First Batch List of Its External Exp...
6/8/2020
NMPA Issues the Guidelines for Essential Document Storage of Drug Clin...
6/8/2020
NMPA Solicits Comments on the Rules for Medical Representative Filing ...
6/7/2020
Sanofi Launches Orphan Drug Fabrazyme in China
6/5/2020
NHSA Drafts the Guidance Opinions for Drug Price and Tender Procuremen...
6/5/2020
China Issues the Notice for Highlights of Correction of Irregularities...
6/5/2020
CDE Solicits Comments on the Technical Guidelines for Clinical Design ...
6/5/2020
CDE Solicits Comments on the Technical Guidelines for Clinical Communi...
6/5/2020
Recent Executive Moves
6/4/2020
USTR Satisfied with China's Implementatin of Phase 1 US-China Trade De...
6/4/2020
Beijing Plans to Criminalize Criticisms of Traditional Chinese Medicin...
6/4/2020
Everest Medicines Completes $310 Million Series C Financing
6/3/2020
Oncodesign Establishes Strategic Alliance with HitGen to Strengthen It...
6/3/2020
BeiGene Announces the Approval of BRUKINSA (Zanubrutinib) in China
Page:
179
/
719
Total number of articles:
21568
:
[First]
[<<]
[177]
[178]
[179]
[180]
[181]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit